Atlas Arteria Limited
MAQAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 4.19 | 0.00 | 0.90 | -0.15 |
| FCF Yield | 1.44% | 8.86% | 5.24% | 0.41% |
| EV / EBITDA | 17.79 | 22.23 | 26.11 | 295.34 |
| Quality | ||||
| ROIC | -0.10% | 1.08% | -0.30% | 0.92% |
| Gross Margin | 95.66% | 12.24% | 0.10% | -9.00% |
| Cash Conversion Ratio | – | 0.26 | 1.96 | 0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.50% | 10.06% | 3.06% | 4,649,443.25% |
| Free Cash Flow Growth | -87.08% | 50.65% | 1,126.87% | 60.69% |
| Safety | ||||
| Net Debt / EBITDA | 3.37 | 3.32 | 3.64 | 38.68 |
| Interest Coverage | -0.09 | 0.91 | -0.27 | 0.36 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -636.06 | 61.32 | 780.11 | 26.56 |